TENAX THERAPEUTICS, INC. Payments to Acquire Marketable Securities
TENAX THERAPEUTICS, INC. (TENX) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2023-03-31
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2022-12-31 was $0.00.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2022-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2021 was $345.54K, a 42.07% decline from fiscal 2020.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2020 was $596.52K, a 3.49% decline from fiscal 2019.
- TENAX THERAPEUTICS, INC. payments to acquire marketable securities for fiscal 2019 was $618.10K, a 25.17% increase from fiscal 2018.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 8 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $0.00 derived: sum of 4 quarters · filed 2023-03-31 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 derived: sum of 3 quarters · filed 2023-03-31 | $118.39K derived: sum of 4 quarters · filed 2023-03-31 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $118.39K derived: sum of 3 quarters · filed 2023-03-31 | $345.54K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $118.39K derived: sum of 2 quarters · filed 2022-11-10 | $345.54K 10-Q · filed 2022-11-10 | $483.63K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $118.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $345.54K 10-Q · filed 2022-08-11 | $483.63K derived: sum of 3 quarters · filed 2022-08-11 | $590.93K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $227.15K 10-Q · filed 2022-05-16 | $365.23K derived: sum of 2 quarters · filed 2022-05-16 | $472.53K derived: sum of 3 quarters · filed 2022-05-16 | $677.37K derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $138.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $245.39K derived: sum of 2 quarters · filed 2022-03-29 | $450.23K derived: sum of 3 quarters · filed 2022-03-29 | $596.52K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $107.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $312.14K derived: sum of 2 quarters · filed 2021-11-15 | $458.44K 10-Q · filed 2021-11-15 | $640.18K derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $204.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $351.14K 10-Q · filed 2021-08-16 | $532.88K derived: sum of 3 quarters · filed 2021-08-16 | $693.80K derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $146.30K 10-Q · filed 2021-05-17 | $328.04K derived: sum of 2 quarters · filed 2021-05-17 | $488.96K derived: sum of 3 quarters · filed 2021-05-17 | $694.17K derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $181.74K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $342.67K derived: sum of 2 quarters · filed 2021-04-16 | $547.87K derived: sum of 3 quarters · filed 2021-04-16 | $618.10K 10-K/A · filed 2021-04-16 | |
| 2019-09-30 | $160.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $366.13K derived: sum of 2 quarters · filed 2020-11-16 | $436.36K 10-Q · filed 2020-11-16 | $930.18K derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $205.20K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $275.44K 10-Q · filed 2020-08-14 | $769.26K derived: sum of 3 quarters · filed 2020-08-14 | $769.26K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $70.23K 10-Q · filed 2020-05-15 | $564.05K derived: sum of 2 quarters · filed 2020-05-15 | $564.05K derived: sum of 3 quarters · filed 2020-05-15 | $564.05K derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $493.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $493.82K derived: sum of 2 quarters · filed 2020-03-30 | $493.82K derived: sum of 3 quarters · filed 2020-03-30 | $493.82K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | $0.00 derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $0.00 10-Q · filed 2019-08-14 | $0.00 derived: sum of 3 quarters · filed 2019-08-14 | $0.00 derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 | $0.00 derived: sum of 2 quarters · filed 2019-05-15 | $0.00 derived: sum of 3 quarters · filed 2019-05-15 | $0.00 derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $0.00 derived: sum of 2 quarters · filed 2019-04-01 | $0.00 derived: sum of 3 quarters · filed 2019-04-01 | $299.17K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $299.17K 10-Q · filed 2018-11-14 | $299.17K derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $299.17K 10-Q · filed 2018-08-14 | $299.17K derived: sum of 3 quarters · filed 2018-08-14 | $299.17K derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $299.17K 10-Q · filed 2018-05-15 | $299.17K derived: sum of 2 quarters · filed 2018-05-15 | $299.17K derived: sum of 3 quarters · filed 2018-05-15 | $4.36M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $0.00 derived: sum of 2 quarters · filed 2018-04-02 | $4.06M derived: sum of 3 quarters · filed 2018-04-02 | $7.26M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $4.06M derived: sum of 2 quarters · filed 2017-11-09 | $7.26M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | $4.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $7.26M 10-Q · filed 2017-08-09 | |||
| 2016-03-31 | $3.20M 10-Q · filed 2017-05-10 | ||||
| 2015-12-31 | $5.55M 10-K · filed 2017-03-16 | ||||
| 2015-10-31 | $999.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | $5.22M 10-Q · filed 2015-12-10 | |||
| 2015-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $15.81M 10-Q · filed 2016-11-09 | |||
| 2015-07-31 | $4.22M 10-Q · filed 2015-09-09 | ||||
| 2015-06-30 | $4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $12.11M 10-Q · filed 2016-08-09 | |||
| 2015-04-30 | $10.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $55.14M 10-K · filed 2017-03-16 | |||
| 2015-03-31 | $7.85M 10-Q · filed 2016-05-10 | ||||
| 2015-01-31 | $3.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | $9.18M derived: sum of 2 quarters · filed 2015-12-10 | $44.81M 10-Q · filed 2015-03-17 | $44.81M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2014-10-31 | $6.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | $41.66M 10-Q · filed 2015-12-10 | $41.66M derived: sum of 3 quarters · filed 2017-03-16 | ||
| 2014-07-31 | $35.63M 10-Q · filed 2015-09-09 | $35.63M derived: sum of 2 quarters · filed 2017-03-16 | |||
| 2014-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | |||
| 2014-01-31 | $0.00 10-Q · filed 2015-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |